Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Nitrogen containing other than solely as a nitrogen in an...
Reexamination Certificate
2011-07-19
2011-07-19
Powers, Fiona T (Department: 1626)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Nitrogen containing other than solely as a nitrogen in an...
C564S102000
Reexamination Certificate
active
07981935
ABSTRACT:
The present invention relates to screens for compounds that can induce stem cell differentiation. In addition, isoxazoles and sulfonyl hydrazones are identified as general classes of compounds that can induce differentiation of stem cells into cells of neuronal and cardiac fate, respectively.
REFERENCES:
patent: 5201932 (1993-04-01), Maywald et al.
patent: 0 418 667 (1991-03-01), None
patent: 08-027130 (1996-01-01), None
patent: WO 03/013517 (2003-02-01), None
patent: WO 2009/006267 (2009-01-01), None
Rawat et al., Chemical Abstracts, 110:74706, 1989.
Ozmen et al., Spectrochimica Acta, Part A, 70, 641-645, 2008.
Shyam et al., Journal of Medicinal Chemistry, 39, 796-801, 1996.
Chandrasekhar et al., “Direct conversion of tosylhydrazones to tert-butyl ethers under bamford-stevens reaction conditions,”Synlett., 1779-1780, 2001.
Chi et al., Production of green fluorescent protein transgenic embryonic stem cells using the GENSAT bacterial artificial chromosome library,PNAS, 102:13490-13495, 2005.
Creemers et al., “Myocardin is a direct transcriptional target of Mef2, Tead and Foxo proteins during cardiovascular development,”Development, 133:4245-4256, 2006.
Database Chemcats Chemical Abstract Service, XP002509165 retrieved from STN order numbers: AKL-P-1661072, AKL-P-1660956, AKL-P-1661210, AKL-P-1413044, AKL-P-1660951, AKL-P-1753501, Feb. 7, 2006.
Elliott et al., “A tyrosine-rich domain within homeodomain transcription factor Nkx2-5 is an essential element in the early cardiac transcriptional regulatory machinery,”Development, 133:1311-22, 2006.
Hidaka et al., “Chamber-specific differentiation of Nkx2.5-positive cardiac precursor cells from murine embryonic stem cells,”The FASEB Journal, published online Feb. 19, 2003.
Hsieh et al., “Histone deacetylase inhibition-mediated neuronal differentiation of multipotent adult neural progenitor cells,”Proc. Natl. Acad. Sci. USA, 101:16659-16664, 2004.
Hsieh et al., “IGF-I instructs multipotent adult neural progenitor cells to become oligodendrocytes,”J. Cell Biol., 164:111-122, 2004.
International Partial Search Report issued in Application No. PCT/US2008/071843, dated Jan. 26, 2009.
Larabi et al., “Synthesis, structural study and electrochemical properties of copper(II) complexes derived from benzene- and p-toluenesulphonylhydrazones,”J. Serb. Chem. Soc., 68:85-95, 2003.
Leopoldo et al., “Design, synthesis, and binding affinities of potential positron emission tomography (PET) ligands for visualization of brain dopamine D-3 receptors,”J. Med. Chem., 49:358-365, 2006.
Morissette et al., “High-throughput crystallization: polymorphs, salts, co-crystals and solvates of pharmaceutical solids,”Advanced Drug Delivery Reviews, 56:275-300, 2004.
Munshi et al., “Synthesis of aryl sulphonyl hydrazones and I-aryl sulphonyl 4-substituted thiosemicarbzaides,”Indian J. Chem., 1:311-313, 1963.
Office Action issued in related U.S. Appl. No. 11/974,479, mail date May 1, 2009.
Response to Office Action issued in related U.S. Appl. No. 11/974,479, submitted Oct. 1, 2009.
Office Action issued in related U.S. Appl. No. 11/974,479, mail date Dec. 17, 2009.
Pipes et al., “The myocardin family of transcriptional coactivators: versatile regulators of cell growth, migration, and myogenesis,”Genes and Develop., 20:1545-1556, 2006.
Sasaki et al., “Novel generation and cycloaddition reactivity of n-phenylsulfonylbenzonitrilimine via thermal decomposition of n-(phenylsulfonyl)benzohydrazonoyl chloride,”Tetrahedrom, 36:1565-1569, 1980.
Schneider and Olson, “Small molecules and the pharmacology of cardiac cell fate,” Circulation Research 99 (5): pE37, Conference/meeting—3rdAnnual Symposium of the American-Heart-Association-Council-on-Basic-Cardiovascular-Sciences, Keystone, CO, USA, Jul. 31-Aug. 3, 2006.
Siemann et al., “N-arylsulfonyl hydrazones as inhibitors of IMP-1 metallo-β-lactamase,”Antimicrobial Agents and Chemotherapy, 46:2450-2457, 2002.
Souillac and Rytting, “Characterization of delivery systems, differential scanning calorimetry,”In: Encyclopedia of Controlled Drug Delivery, John Wiley and Sons, pp. 212-227, 1999.
Suk Kim et al., “Expression of ErbB receptors in ES cell-derived cardiomyocytes,”Biochem. Biophys. Res. Commun., 309:241-6, 2003.
Takahashi et al., “Ascorbic acid enhances differentiation of embryonic stem cells into cardiac myocytes,”Circulation, 107:1912-1916, 2003.
Tomishima et al., “Production of green fluorescent protein transgenic embryonic stem cells using the GENSAT bacterial artificial chromosome library,”Stem Cells., 25:39-45, 2007.
Vippagunta et al., “Crystalline solids,”Advanced Drug Delivery Reviews, 48:3-26, 2001.
Yamashita et al., “Prospective identification of cardiac progenitors by a novel single cell-based cardiomyocyte induction,”FASEB J., 19:1534-1536, 2005.
Frantz Douglas
Hsieh Jenny
McKnight Steven L.
Olson Eric
Schneider Jay
Fulbright & Jaworski
Powers Fiona T
The Board of Regents of the University of Texas System
LandOfFree
Stem cell differentiating agents and uses therefor does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Stem cell differentiating agents and uses therefor, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Stem cell differentiating agents and uses therefor will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2621222